Skip to main content
. Author manuscript; available in PMC: 2022 Oct 26.
Published in final edited form as: Mol Cancer Ther. 2022 Mar 1;21(3):397–406. doi: 10.1158/1535-7163.MCT-21-0455

Figure 5.

Figure 5.

Effect of OKI-179 or tamoxifen alone or in combination in MCF7 xenograft BALB/c nude mouse model. A) Tumor volumes for mice treated with OKI-179 PO 5 days on 2 days off, tamoxifen SQ 3 times a week or the combination. B) Probability of survival for MCF7 xenograft mice treated with OKI-179, tamoxifen or the combination.